4.2 Article

Uracil excision repair in Mycobacterium tuberculosis cell-free extracts

期刊

TUBERCULOSIS
卷 91, 期 3, 页码 212-218

出版社

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.tube.2011.02.001

关键词

Ung; UdgB; Short-patch repair; Long-patch repair

资金

  1. Department of Biotechnology, New Delhi, India
  2. Government of India

向作者/读者索取更多资源

Uracil excision repair is ubiquitous in all domains of life and initiated by uracil DNA glycosylases (UDGs) which excise the promutagenic base, uracil, from DNA to leave behind an abasic site (AP-site). Repair of the resulting AP-sites requires an AP-endonuclease, a DNA polymerase, and a DNA ligase whose combined activities result in either short-patch or long-patch repair. Mycobacterium tuberculosis, the causative agent of tuberculosis, has an increased risk of accumulating uracils because of its G + C-rich genome, and its niche inside host macrophages where it is exposed to reactive nitrogen and oxygen species, two major causes of cytosine deamination (to uracil) in DNA. In vitro assays to study DNA repair in this important human pathogen are limited. To study uracil excision repair in mycobacteria, we have established assay conditions using cell-free extracts of M. tuberculosis and M. smegmatis (a fast-growing mycobacterium) and oligomer or plasmid DNA substrates. We show that in mycobacteria, uracil excision repair is completed primarily via long-patch repair. In addition, we show that M. tuberculosis UdgB, a newly characterized family 5 UDG, substitutes for the highly conserved family 1 UDG, Ung, thereby suggesting that UdgB might function as backup enzyme for uracil excision repair in mycobacteria. (C) 2011 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure

Stephanus T. Malherbe, Shubhada Shenai, Katharina Ronacher, Andre G. Loxton, Gregory Dolganov, Magdalena Kriel, Tran Van, Ray Y. Chen, James Warwick, Laura E. Via, Taeksun Song, Myungsun Lee, Gary Schoolnik, Gerard Tromp, David Alland, Clifton E. Barry, Jill Winter, Gerhard Walzl

NATURE MEDICINE (2016)

Article Microbiology

A Novel Small-Molecule Inhibitor of the Mycobacterium tuberculosis Demethylmenaquinone Methyltransferase MenG Is Bactericidal to Both Growing and Nutritionally Deprived Persister Cells

Paridhi Sukheja, Pradeep Kumar, Nisha Mittal, Shao-Gang Li, Eric Singleton, Riccardo Russo, Alexander L. Perryman, Riju Shrestha, Divya Awasthi, Seema Husain, Patricia Soteropoulos, Roman Brukh, Nancy Connell, Joel S. Freundlich, David Alland

Article Microbiology

Novel Pyrimidines as Antitubercular Agents

Daigo Inoyama, Steven D. Paget, Riccardo Russo, Srinivasan Kandasamy, Pradeep Kumar, Eric Singleton, James Occi, Margareta Tuckman, Matthew D. Zimmerman, Hsin Pin Ho, Alexander L. Perryman, Veronique Dartois, Nancy Connell, Joel S. Freundlich

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Biochemistry & Molecular Biology

Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis

Regina Wilson, Pradeep Kumar, Vijay Parashar, Catherine Vilcheze, Romain Veyron-Churlet, Joel S. Freundlich, S. Whitney Barnes, John R. Walker, Michael J. Szymonifka, Emily Marchiano, Shubhada Shenai, Roberto Colangeli, William R. Jacobs, Matthew B. Neiditch, Laurent Kremer, David Alland

NATURE CHEMICAL BIOLOGY (2013)

Article Multidisciplinary Sciences

Combining Metabolite-Based Pharmacophores with Bayesian Machine Learning Models for Mycobacterium tuberculosis Drug Discovery

Sean Ekins, Peter B. Madrid, Malabika Sarker, Shao-Gang Li, Nisha Mittal, Pradeep Kumar, Xin Wang, Thomas P. Stratton, Matthew Zimmerman, Carolyn Talcott, Pauline Bourbon, Mike Travers, Maneesh Yadav, Joel S. Freundlich

PLOS ONE (2015)

Article Immunology

The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase

Giorgia Mori, Beatrice Silvia Orena, Clara Franch, Lesley A. Mitchenall, Adwait Anand Godbole, Liliana Rodrigues, Clara Aguilar-Perez, Julia Zemanova, Stanislav Huszar, Martin Forbak, Thomas R. Lane, Mohamad Sabbah, Nathalie Deboosere, Rosangela Frita, Alexandre Vandeputte, Eik Hoffmann, Riccardo Russo, Nancy Connel, Courtney Veilleux, Rajiv K. Jha, Pradeep Kumar, Joel S. Freundlich, Priscille Brodin, Jose Antonio Ainsa, Valakunja Nagaraja, Anthony Maxwell, Katarina Mikusova, Maria Rosalia Pasca, Sean Ekins

TUBERCULOSIS (2018)

Article Chemistry, Medicinal

Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent

Ricardo Gallardo-Macias, Pradeep Kumar, Mark Jaskowski, Todd Richmann, Riju Shrestha, Riccardo Russo, Eric Singleton, Matthew D. Zimmerman, Hsin Pin Ho, Veronique Dartois, Nancy Connell, David Alland, Joel S. Freundlich

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Article Microbiology

Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA

Pradeep Kumar, Glenn C. Capodagli, Divya Awasthi, Riju Shrestha, Karishma Maharaja, Paridhi Sukheja, Shao-Gang Li, Daigo Inoyama, Matthew Zimmerman, Hsin Pin Ho Liang, Jansy Sarathy, Marizel Mina, George Rasic, Riccardo Russo, Alexander L. Perryman, Todd Richmann, Aditi Gupta, Eric Singleton, Sheetal Verma, Seema Husain, Patricia Soteropoulos, Zhe Wang, Roxanne Morris, Gene Porter, Gautam Agnihotri, Padmini Salgame, Sean Ekins, Kyu Y. Rhee, Nancy Connell, Veronique Dartois, Matthew B. Neiditch, Joel S. Freundlich, David Alland

Article Chemistry, Medicinal

Intrabacterial Metabolism Obscures the Successful Prediction of an InhA Inhibitor of Mycobacterium tuberculosis

Xin Wang, Alexander L. Perryman, Shao-Gang Li, Steve D. Paget, Thomas P. Stratton, Alex Lemenze, Arthur J. Olson, Sean Ekins, Pradeep Kumar, Joel S. Freundlich

ACS INFECTIOUS DISEASES (2019)

Review Chemistry, Medicinal

Base excision repair pathways of bacteria: new promise for an old problem

Krishna Kurthkoti, Pradeep Kumar, Pau Biak Sang, Umesh Varshney

FUTURE MEDICINAL CHEMISTRY (2020)

Article Microbiology

Compromised base excision repair pathway in Mycobacterium tuberculosis imparts superior adaptability in the host

Saba Naz, Shruti Dabral, Sathya Narayanan Nagarajan, Divya Arora, Lakshya Veer Singh, Pradeep Kumar, Yogendra Singh, Dhiraj Kumar, Umesh Varshney, Vinay Kumar Nandicoori

Summary: Deleting a DNA repair pathway in Mycobacterium tuberculosis has been shown to increase bacterial mutation rate under antibiotic stress, improve survival in a guinea pig infection model, and potentially identify new antibiotic targets.

PLOS PATHOGENS (2021)

Article Oncology

Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression

Stephanie A. Sheehan, Kelly L. Hamilton, Edward P. Retzbach, Premalatha Balachandran, Harini Krishnan, Paola Leone, Moises Lopez-Gonzalez, Shraddha Suryavanshi, Pradeep Kumar, Riccardo Russo, Gary S. Goldberg

Summary: COVID-19 was declared a global public health emergency and pandemic in 2020, with over 125 million confirmed cases and 2.7 million deaths worldwide as of March 2021. The SARS-CoV-2 virus causing COVID-19 infects host cells by binding its spike protein to the ACE2 receptor, which is also found in oral mucosa cells. Maackia amurensis seed lectin (MASL) has shown potential as an antiviral agent by targeting the ACE2 receptor, reducing ACE2 expression and glycosylation, inhibiting SARS-CoV-2 spike protein binding, and decreasing inflammation in oral epithelial cells and kidney epithelial cells.

EXPERIMENTAL CELL RESEARCH (2021)

Article Chemistry, Medicinal

Bayesian Modeling and Intrabacterial Drug Metabolism Applied to Drug-Resistant Staphylococcus aureus

Jimmy S. Patel, Javiera Norambuena, Hassan Al-Tameemi, Yong-Mo Ahn, Alexander L. Perryman, Xin Wang, Samer S. Daher, James Occi, Riccardo Russo, Steven Park, Matthew Zimmerman, Hsin-Pin Ho, David S. Perlin, Veronique Dartois, Sean Ekins, Pradeep Kumar, Nancy Connell, Jeffrey M. Boyd, Joel S. Freundlich

Summary: The study applied Bayesian modeling to identify chemical tools and drug discovery entities for drug-resistant Staphylococcus aureus infections, leading to the discovery of the active quinoline JSF-3151 and investigation of its intrabacterial transformation mechanism. Resistance mechanisms involving increased expression of a lipocalin protein and loss of function of an azoreductase in S. aureus were identified and validated, offering insights for developing therapeutic regimens for drug-resistant S. aureus.

ACS INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA

Daigo Inoyama, Divya Awasthi, Glenn C. Capodagli, Kholiswa Tsotetsi, Paridhi Sukheja, Matthew Zimmerman, Shao-Gang Li, Ravindra Jadhav, Riccardo Russo, Xin Wang, Courtney Grady, Todd Richmann, Riju Shrestha, Liping Li, Yong-Mo Ahn, Hsin Pin Ho Liang, Marizel Mina, Steven Park, David S. Perlin, Nancy Connell, Veronique Dartois, David Alland, Matthew B. Neiditch, Pradeep Kumar, Joel S. Freundlich

CELL CHEMICAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Antitubercular Triazines: Optimization and Intrabacterial Metabolism

Xin Wang, Daigo Inoyama, Riccardo Russo, Shao-Gang Li, Ravindra Jadhav, Thomas P. Stratton, Nisha Mittal, Joseph A. Bilotta, Eric Singleton, Thomas Kim, Steve D. Paget, Richard S. Pottorf, Yong-Mo Ahn, Alejandro Davila-Pagan, Srinivasan Kandasamy, Courtney Grady, Seema Hussain, Patricia Soteropoulos, Matthew D. Zimmerman, Hsin Pin Ho, Steven Park, Veronique Dartois, Sean Ekins, Nancy Connell, Pradeep Kumar, Joel S. Freundlich

CELL CHEMICAL BIOLOGY (2020)

暂无数据